首页 | 本学科首页   官方微博 | 高级检索  
检索        

钙与血透患者的甲旁腺功能
引用本文:徐启河,刘平,姜筠,吴希云,黄颖.钙与血透患者的甲旁腺功能[J].肾脏病与透析肾移植杂志,1993(1).
作者姓名:徐启河  刘平  姜筠  吴希云  黄颖
作者单位:解放军总医院肾内科,北京医科大学第一医院肾内科,北京医科大学第一医院肾内科,天坛医院检验科,中国药品生物制品检定所激素室 100853,100034,100034
摘    要:本文监测了18例维持性血透患者的血清总钙(Ca)、校正离子钙(nCa_-~(2+))、全血离子钙(bCa_-~(2+))、血清磷(P)、血清全段甲旁腺激素(I-PTH),并观察口服肾骨胶囊3周及高钙透析4h对以上指标的影响。结果表明:低钙血症是血透患者继发甲旁亢的重要原因,提升血钙可抑制多数患者的甲旁腺功能。纠正低血钙的方法中以口服钙磷结合剂为首选,只有纠正了低钙、高磷血症后甲旁腺功能仍不得控制者可推荐使用活性维生素D治疗。二者对防治高钙血症都具有重要意义。

关 键 词:  维持性血液透析  钙磷结合剂  继发性甲状旁腺功能亢进

Relation between calcium and parathyroid status of hemodialysis patients
Xu Qihe,.Relation between calcium and parathyroid status of hemodialysis patients[J].Chinese Journal of Nephrology, Dialysis & Transplantation,1993(1).
Authors:Xu Qihe  
Abstract:Serum calcium, ionized calcium, phosphorus, intact parathyroid hormone and whole blood ionized calcium were monitored in 18 maintenance hemodialysis (MHD) patients, and the effects of a 3-week Shengu-capsule treatment and a 4-hour high calcium hemodialysis treatment on the above parameters were observed. Results showed that hypoealcemia is an important etiological factor of secondary, parathyroidism(2-HPT), and that 2-HPT could be ameliorated by elevating serum calcium. Although more dietary calcium, high calcium hemodialysis, vitamin D metabolite and calcium phosphorus binder administration could all be effective in correcting hypocalcemia, calcium phosphorus binders should be the first choice.
Keywords:calcium  secondary parathyroidism  calcium phosphorus binder  high calcium hemodialysis
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号